Posted by Michael Wonder on 04 Oct 2020
Budget to deliver better access to life changing medicines for liver cancer, eye conditions and Parkinson’s disease
4 October 2020 - In Tuesday’s Budget, the Morrison Government will provide significant investment for new medicines including over $230 million to expand the listing Tecentriq and Avastin (atezolizumab and bevacizumab) on the PBS for use in combination to treat patients with advanced unresectable hepatocellular carcinoma.
This PBS listing has been implemented only two months after TGA registration, after it was assessed through the new TGA provisional approval pathway and considered for funding in parallel by the expert PBAC.
